These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30868963)

  • 1. 2,4-Disubstituted Quinazoline Derivatives Act as Inducers of Tubulin Polymerization: Synthesis and Cytotoxicity.
    Moghadam ES; Tehrani MH; Csuk R; Fischer L; Faramarzi MA; Rashidi A; Javadi I; Amini M
    Anticancer Agents Med Chem; 2019; 19(8):1048-1057. PubMed ID: 30868963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis and Evaluation of 2,4-Diaminoquinazoline Derivatives as Potential Tubulin Polymerization Inhibitors.
    Herrera-Vázquez FS; Matadamas-Martínez F; Aguayo-Ortiz R; Dominguez L; Ramírez-Apan T; Yépez-Mulia L; Hernández-Luis F
    ChemMedChem; 2020 Oct; 15(19):1802-1812. PubMed ID: 32686342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, cytotoxic evaluation and molecular docking study of 2-alkylthio-4-(2,3,4-trimethoxyphenyl)-5-aryl-thiazoles as tubulin polymerization inhibitors.
    Salehi M; Amini M; Ostad SN; Riazi GH; Assadieskandar A; Shafiei B; Shafiee A
    Bioorg Med Chem; 2013 Dec; 21(24):7648-54. PubMed ID: 24238904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
    Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
    Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro Biological Evaluation of Ferrocenyl Side-Chain-Functionalized Paclitaxel Derivatives.
    Plażuk D; Wieczorek A; Ciszewski WM; Kowalczyk K; Błauż A; Pawlędzio S; Makal A; Eurtivong C; Arabshahi HJ; Reynisson J; Hartinger CG; Rychlik B
    ChemMedChem; 2017 Nov; 12(22):1882-1892. PubMed ID: 28941201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bestowal of Quinazoline Scaffold in Anticancer Drug Discovery.
    Das R; Mehta DK; Dhanawat M
    Anticancer Agents Med Chem; 2021; 21(11):1350-1368. PubMed ID: 32593282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site.
    Wang G; Peng Z; Zhang J; Qiu J; Xie Z; Gong Z
    Bioorg Chem; 2018 Aug; 78():332-340. PubMed ID: 29627654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Cytotoxicity and Molecular Docking Studies of the 9-Substituted 5-Styryltetrazolo[1,5-c]quinazoline Derivatives.
    Mphahlele MJ; Gildenhuys S; Parbhoo N
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29072619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
    Ramya PVS; Guntuku L; Angapelly S; Digwal CS; Lakshmi UJ; Sigalapalli DK; Babu BN; Naidu VGM; Kamal A
    Eur J Med Chem; 2018 Jan; 143():216-231. PubMed ID: 29174816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
    El-Adl K; Ibrahim MK; Alesawy MSI; Eissa IH
    Bioorg Med Chem; 2021 Jan; 30():115958. PubMed ID: 33360576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modelling and synthesis of quinazoline-based compounds as potential antiproliferative agents.
    Yassen AS; Elshihawy HE; Said MM; Abouzid KA
    Chem Pharm Bull (Tokyo); 2014; 62(5):454-66. PubMed ID: 24789927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of N-substituted 3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylic acid derivatives as tubulin polymerization inhibitors.
    Qi J; Dong H; Huang J; Zhang S; Niu L; Zhang Y; Wang J
    Eur J Med Chem; 2018 Jan; 143():8-20. PubMed ID: 29172084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of thiazole linked indolyl-3-glyoxylamide derivatives as tubulin polymerization inhibitors.
    Guggilapu SD; Guntuku L; Reddy TS; Nagarsenkar A; Sigalapalli DK; Naidu VGM; Bhargava SK; Bathini NB
    Eur J Med Chem; 2017 Sep; 138():83-95. PubMed ID: 28648953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Anticancer and Anti-Mitotic Properties of Quinazoline and Quinazolino-Benzothiadiazine Derivatives.
    Shaik TB; Malik MS; Routhu SR; Seddigi ZS; Althagafi II; Kamal A
    Anticancer Agents Med Chem; 2020; 20(5):599-611. PubMed ID: 31884931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation.
    Naret T; Bignon J; Bernadat G; Benchekroun M; Levaique H; Lenoir C; Dubois J; Pruvost A; Saller F; Borgel D; Manoury B; Leblais V; Darrigrand R; Apcher S; Brion JD; Schmitt E; Leroux FR; Alami M; Hamze A
    Eur J Med Chem; 2018 Jan; 143():473-490. PubMed ID: 29202409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents.
    Poudapally S; Battu S; Velatooru LR; Bethu MS; Janapala VR; Sharma S; Sen S; Pottabathini N; Iska VBR; Katangoor V
    Bioorg Med Chem Lett; 2017 May; 27(9):1923-1928. PubMed ID: 28351589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-Pot Synthesis of Triazolo-Heterolignans: Biological Evaluation and Molecular Docking Studies as Tubulin Inhibitors.
    Reddy CR; Subbarao M; Vijaykumar J; Jadav SS; Sasane N; Valleti RR; Supriya B; Ummanni R
    Anticancer Agents Med Chem; 2018; 18(12):1702-1710. PubMed ID: 30019651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)nicotinamides as potential anticancer agents that inhibit tubulin polymerization.
    Kamal A; Reddy NV; Nayak VL; Bolla NR; Subba Rao AV; Prasad B
    Bioorg Med Chem; 2014 Jul; 22(13):3465-77. PubMed ID: 24835786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of novel benzodiazepine derivatives as anticancer agents through inhibition of tubulin polymerization in vitro and in vivo.
    Pang Y; Lin H; Ou C; Cao Y; An B; Yan J; Li X
    Eur J Med Chem; 2019 Nov; 182():111670. PubMed ID: 31499359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.